Dichloromethane → 5-{5-[(4-benzyl-4-hydroxypiperidin-1-yl)methyl]2-thienyl}2-tertbutylisothiazol-3(2H)-one 1,1-dioxide trifluoroacetate
반응식
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH2:8]([C:15]1([OH:30])[CH2:20][CH2:19][N:18]([CH2:21][C:22]2[S:26][C:25](B(O)O)=[CH:24][CH:23]=2)[CH2:17][CH2:16]1)[C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1.[C:31]([N:35]1[C:39](=[O:40])[CH:38]=[C:37](Cl)[S:36]1(=[O:43])=[O:42])([CH3:34])([CH3:33])[CH3:32].C(=O)([O-])[O-].[K+].[K+].ClCCl>O1CCOCC1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH2:8]([C:15]1([OH:30])[CH2:20][CH2:19][N:18]([CH2:21][C:22]2[S:26][C:25]([C:37]3[S:36](=[O:42])(=[O:43])[N:35]([C:31]([CH3:33])([CH3:32])[CH3:34])[C:39](=[O:40])[CH:38]=3)=[CH:24][CH:23]=2)[CH2:17][CH2:16]1)[C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 80 °C
실험 절차
A solution of 4.12-A (100 mg, 0.2 mmol), 9-A (55 mg, 0.25 mmol), potassium carbonate (190 mg, 1.3 mmol) in 1,4-dioxane (1.5 mL) was added to a vial and degassed with nitrogen. Then [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with dichloromethane (1:1) (28 mg, 0.034 mmol) was added, degassed with nitrogen and the vial capped and heated at 80° C. overnight. The reaction mixture was filtered through silica gel and eluted with copious amounts of EtOAc. The solvent was concentrated and crude sample purified by reverse phase HPLC to afford 20 mg (15%) of 4.12-B. LCMS found for C24H30N2O4S2 (M+H)+: m/z=475.
후처리
- customdegassed with nitrogen
- customdegassed with nitrogen
- customthe vial capped
- filtrationThe reaction mixture was filtered through silica gel
- washeluted with copious amounts of EtOAc
- concentrationThe solvent was concentrated
- customcrude sample purified by reverse phase HPLC
출처 및 근거
- ORD 기록
- ord-5da0916eddb9466d8523fdbf9746e7dc
- 출처 데이터셋
- uspto-grants-2006_11
- 특허 번호
- US07141596B2
반응 노트
불러오는 중…